AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

LH · NYSE · Medical - Diagnostics & Research

Labcorp (LH)

Provides clinical diagnostics and global laboratory support for biopharma research.

$311.54

After hours+0.15 (+0.05%)

At close$311.39(−2.99%)

In millions of USD, except per-share figures

In millions	Q3 FY23Sep 2023	Q4 FY23Dec 2023	Q1 FY24Mar 2024	Q2 FY24Jun 2024	Q3 FY24Sep 2024	Q4 FY24Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Revenue	3,057	3,033	3,177	3,221	3,282	3,329	3,345	3,527	3,564	3,516	3,538	3,731
Cost of revenue	2,206	2,212	2,279	2,295	2,378	2,433	2,397	2,481	2,538	2,595	2,599	2,619
Gross profit	851	821	897	926	904	896	948	1,046	1,025	921	938	1,112
	599	944	576	632	650	680	622	652	629	539	551	660
Research & development	0	2	0	0	0	0	0	0	0	0	0	0
	526	533	508	558	569	595	546	579	552	539	551	577
General & administrative	0	0	0	0	0	0	0	0	0	0	0	577
Other expenses	73	409	68	74	82	85	76	72	76	0	0	83
Operating income	252	−123	321	295	254	217	326	395	397	382	387	452
	−14	−24	−24	−27	−44	−33	−51	−90	−60	−191	−68	−65
Interest income	0	0	0	0	0	0	0	2	0	4	12	6
Interest expense	50	49	47	48	50	63	56	57	56	55	55	61
Other non-operating income	−37	−341	−23	−21	−7	−31	−5	33	4	136	12	10
Income before tax	239	−147	297	268	211	184	275	305	337	191	320	386
Income tax expense	55	20	69	62	41	40	62	66	76	26	42	87
Net income from continuing operations	184	−167	228	206	170	144	213	238	262	165	278	299
Net income	183	−167	228	205	169	143	213	238	261	165	278	299
EPS, basic	$2.12	−$1.97	$2.71	$2.44	$2.02	$1.72	$2.54	$2.86	$3.14	$2.00	$3.37	$3.66
EPS, diluted	$2.11	−$1.97	$2.69	$2.44	$2.01	$1.70	$2.52	$2.84	$3.12	$1.98	$3.35	$3.64
Weighted average shares, basic	87	85	84	84	84	84	84	84	83	83	82	82
Weighted average shares, diluted	87	85	85	84	84	84	84	84	84	83	83	82
EBITDA	478	295	499	472	423	418	498	532	564	419	548	621
Depreciation & amortization	189	77	155	157	162	171	167	170	171	173	173	179
EBIT	289	218	344	315	261	247	331	362	393	246	375	442